French bio-based surfactants firm SurfactGreen has received €4.7 million in investment, with €3.1 million in grants and repayable advances from ADEME and Bpifrance and €1.6 million in capital from its shareholders. This will enable it to double the workforce to 24, start international sales and accelerate the commercialisation of its products, the firm said.
Nippon Shokubai and its Japanese compatriot Summit Cosmetics, a subsidiary of Sumitomo, have entered into a Memorandum of Understanding for the joint development and sales of next-generation personal care ingredient fields. Both are initially investigating new film forming agents and thickeners, including biopolymers.
Croda International has acquired Spanish-based flavours and fragrances (F&F) firm Iberchem from Eurazeo in a €820 million deal. This takes the company into F&F for the first time. It will be funded by existing debt facilities and a £600 equity placing, representing about 8% of Croda’s issued share capital.
Azelis has further strengthened its Asian personal care business by acquiring Bronson and Jacobs Hong Kong and its fully owned subsidiary in Shanghai from Ixom. The deal, for which terms were not disclosed, is expected to close by the end of the year.
Bronson and Jacobs China specialises in the distribution of personal care ingredients, mainly for skin care, for various global principals. It has offices in Hong Kong, Shanghai and Guangzhou, the latter also including a personal care laboratory.
Plant-based ingredients firm Roquette has announced that its first expertise centre in the field of cosmetics will start operating in November. The company said that this is “an important milestone in Roquette Beauté’s development strategy and willingness to be recognised as the B2B expert in plant-based ingredients for cosmetics for the years to come”.
Ken Sipes, director of process systems at EPIC Systems, explains the benefits of designing modular process skids for delayed differentiation
Delayed differentiation, also known as late product differentiation (LPD), refers to the practice of postponing changes to a base product until the end of the manufacturing process. This strategy is widely practised by manufacturers of flavours and fragrances, home and personal care products, adhesives, speciality chemicals and others.
Clariant is expanding its capabilities for the Hostapon SCI brand of isethionate derivatives at its site in Mount Holly, US, and Tarragona, Spain. This will comprise both capacity increases and modernisation via optimised energy consumption and aggregate options for new SI grades. It should come onstream during Q1 2021.